Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease

Terao I, Kodama W
J Alzheimers Dis. 2024; 98(3):825-835. PMID: 38461503. Abstract